Ascenion's COVID-19 related portfolio
Ascenion would like to present to you our portfolio of COVID-19 related technologies in a virtual format. This will be the first part of a series of portfolio presentations. The webinar will take place via Zoom on Wednesday, 6th May.
Ascenion’s Technology Managers will be introducing the following projects:
COVID-19 related portfolio
06.05.20203 pm - 4 pm UTC+2
Therapeutics of COVID-19 and COVID-19 related conditions
COVID-19
23-00080 - Therapeutic Neutralizing Antibodies for Treatment of COVID19 InfectionAntivirals
02-00337 - Novel labyrinthopeptins as anti-viral agentsBacterial Secondary Infection
02-00311 - Cystobactamides – novel antibacterials against gram-negative pathogens
Vaccine Technologies
- 02-00158 - Cyclic di-Nucleotides as adjuvants
Diagnostic Technologies
- 02-00375 - TRACR Detect – novel platform technology for RNA detection based on CRISPR/Cas technology
- 01-00897 - Lateral flow immunoassay with covalently clustered particles for enhanced sensitivity
Research Tools
- 07-00081 - Research tools for COVID-19